Dr. Andrea M Haqq, MD, MHS

Claim this profile

University of Alberta

Studies Obesity
Studies Childhood Obesity
2 reported clinical trials
3 drugs studied

Affiliated Hospitals

Image of trial facility.
University Of Alberta

Clinical Trials Andrea M Haqq, MD, MHS is currently running

Image of trial facility.

Fiber + Metformin

for Severe Childhood Obesity and Insulin Resistance

This is a 12-month, single center, three-arm parallel design, double-blind, randomized clinical trial, to compare the effects of supplemental dietary fiber and metformin (MET) alone and in combination over 12 months on glucose metabolism (insulin resistance \[IR\]), inflammation and BMI in adolescents with obesity and IR, and to assess the relationship between therapeutic intervention(s) and changes in gut microbiome composition and function. Since MET and FIBER have been shown to reduce weight and increase insulin sensitivity through distinct but overlapping mechanisms of action, our central hypothesis is that the combination of FIBER + MET will have a synergistic effect and be more effective than FIBER or MET alone in improving metabolic function (IR) and reducing BMI and inflammation in adolescents with obesity, IR and family history (FM) of T2DM. .
Recruiting2 awards Phase 35 criteria

More about Andrea M Haqq, MD, MHS

Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Andrea M Haqq, MD, MHS has experience with
  • Metformin
  • Supplemental Fiber Mixture
  • Setmelanotide
Breakdown of trials Andrea M Haqq, MD, MHS has run
Obesity
Childhood Obesity
Insulin Resistance
Childhood obesity

Other Doctors you might be interested in

Ming Chan, MD, FRCPCUniversity of Alberta
Doug Klein, MDUniversity of Alberta
Adam Kinnaird, MDUniversity of Alberta

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrea M Haqq, MD, MHS specialize in?
Andrea M Haqq, MD, MHS focuses on Obesity and Childhood Obesity. In particular, much of their work with Obesity has involved treating patients, or patients who are undergoing treatment.
Is Andrea M Haqq, MD, MHS currently recruiting for clinical trials?
Yes, Andrea M Haqq, MD, MHS is currently recruiting for 1 clinical trial in Edmonton Alberta. If you're interested in participating, you should apply.
Are there any treatments that Andrea M Haqq, MD, MHS has studied deeply?
Yes, Andrea M Haqq, MD, MHS has studied treatments such as Metformin, Supplemental fiber mixture, Setmelanotide.
What is the best way to schedule an appointment with Andrea M Haqq, MD, MHS?
Apply for one of the trials that Andrea M Haqq, MD, MHS is conducting.
What is the office address of Andrea M Haqq, MD, MHS?
The office of Andrea M Haqq, MD, MHS is located at: University of Alberta, Edmonton, Alberta T6G 2E1 Canada. This is the address for their practice at the University of Alberta.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security